These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30854738)

  • 1. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
    Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA
    Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
    Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody-Drug Conjugates.
    Matsuda Y; Seki T; Yamada K; Ooba Y; Takahashi K; Fujii T; Kawaguchi S; Narita T; Nakayama A; Kitahara Y; Mendelsohn BA; Okuzumi T
    Mol Pharm; 2021 Nov; 18(11):4058-4066. PubMed ID: 34579528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
    Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
    Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody-Drug Conjugate Synthesis.
    Matsuda Y; Shikida N; Hatada N; Yamada K; Seki T; Nakahara Y; Endo Y; Shimbo K; Takahashi K; Nakayama A; Mendelsohn BA; Fujii T; Okuzumi T; Hirasawa S
    Org Lett; 2024 Jul; 26(27):5597-5601. PubMed ID: 38639400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatographic analysis of site-specific antibody-drug conjugates produced by AJICAP first-generation technology using a recombinant FcγIIIa receptor-ligand affinity column.
    Matsuda Y; Chakrabarti A; Takahashi K; Yamada K; Nakata K; Okuzumi T; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1177():122753. PubMed ID: 34098178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate Production.
    Fujii T; Matsuda Y; Seki T; Shikida N; Iwai Y; Ooba Y; Takahashi K; Isokawa M; Kawaguchi S; Hatada N; Watanabe T; Takasugi R; Nakayama A; Shimbo K; Mendelsohn BA; Okuzumi T; Yamada K
    Bioconjug Chem; 2023 Mar; 34(4):728-38. PubMed ID: 36894324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
    Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
    Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good Manufacturing Practice Strategy for Antibody-Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP.
    Matsuda Y; Clancy C; Tawfiq Z; Robles V; Mendelsohn BA
    ACS Omega; 2019 Dec; 4(24):20564-20570. PubMed ID: 31858041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method development of a novel PK assay for antibody-conjugated drug measurement of ADCs using peptide-linker drug analyte.
    Hyung SJ; Li D; Koppada N; Kaur S; Saad OM
    Anal Bioanal Chem; 2019 May; 411(12):2587-2596. PubMed ID: 30828756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation.
    Lee T; Kim JH; Kwon SJ; Park SH; Kim J; Kang HJ; Chung SJ
    Org Lett; 2020 Nov; 22(21):8419-8423. PubMed ID: 33074682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents.
    Bernardim B; Matos MJ; Ferhati X; Compañón I; Guerreiro A; Akkapeddi P; Burtoloso ACB; Jiménez-Osés G; Corzana F; Bernardes GJL
    Nat Protoc; 2019 Jan; 14(1):86-99. PubMed ID: 30470819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine conjugation properties in human IgGs studied by integrating high-resolution native mass spectrometry and bottom-up proteomics.
    Gautier V; Boumeester AJ; Lössl P; Heck AJ
    Proteomics; 2015 Aug; 15(16):2756-65. PubMed ID: 25641908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
    Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N
    Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies.
    Ohata J; Ball ZT
    J Am Chem Soc; 2017 Sep; 139(36):12617-12622. PubMed ID: 28810739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Modification of Native Antibodies.
    Wu KL; Yu C; Lee C; Zuo C; Ball ZT; Xiao H
    Bioconjug Chem; 2021 Sep; 32(9):1947-1959. PubMed ID: 34428033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
    Kuo WY; Hsu HJ; Wu CY; Chen HS; Chou YC; Tsou YL; Peng HP; Jian JW; Yu CM; Chiu YK; Chen IC; Tung CP; Hsiao M; Lin CL; Wang YA; Wang AH; Yang AS
    MAbs; 2019 Jan; 11(1):153-165. PubMed ID: 30365359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.